Neuropsychopharmacology
- Psychotherapy for older adults with depression: a narrative review6 months ago
- Consciousness, subjectivity, and aging in western thought6 months ago
- Synaptic effects of interleukin-6 on human iPSC-derived dopaminergic neurons7 months ago
- Remission is insufficient: predictors and mechanistic models of recurrence in late-life depression7 months ago
- Modulation of hierarchical motor sequence learning by alpha-synuclein and the adenosine A2A receptor7 months ago
- From rest to focus: pharmacological modulation of the relationship between resting state dorsal attention network dynamics and task-based brain activation7 months ago
- Network-based analysis of differential white matter connectivity in major depressive disorder with and without comorbid anxiety7 months ago
Journal of Psychopharmacology
- Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression1 year ago
- Urological symptoms following ketamine treatment for psychiatric disorders: A systematic review1 year ago
- Effects of initial nicotine exposure on cognition and nicotine reinforcement among non-smoking young adults with and without attention deficit hyperactivity disorder1 year ago
- OAV and 5D-ASC for Brazilian Portuguese: A validation and adaptation study1 year ago
- Acute effects of 150 mg caffeine on subjective, physiological, and behavioral components of anxiety in panic disorder and healthy controls – A randomized placebo-controlled crossover trial1 year ago
- Fluoroquinolones and risk of nightmares: A literature review and disproportionality analysis using individual case safety reports from Food and Drug Administration Adverse Event Reporting System database1 year ago
- A randomized, double-blind, placebo-controlled, Phase 1 study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of an immediate-release oral ketamine capsule in healthy volunteers1 year ago
European Neuropsychopharmacology
- Comparative mortality risk of antipsychotics in 41,695 patients with schizophrenia: an 11-year population-based cohort study in Hong Kong1 year ago
- Pharmacological treatments for atypical depression: A systematic review and network meta-analysis of randomized controlled trials1 year ago
- Association between major cardiovascular events and esketamine: A disproportionality analysis in the WHO pharmacovigilance database1 year ago
- Exploring the prospective association of serum interleukin-1β and brain-derived neurotrophic factor with antidepressant treatment response1 year ago
- Efficacy, safety, and tolerability of JNJ-61393215 (tebideutorexant), a selective orexin-1 receptor antagonist, as adjunctive treatment for major depressive disorder with anxious distress: A double-blind, placebo-controlled, randomized phase 2a study1 year ago
- Supporting the call for clinical trials assessing physical exercise and creatine in depression: a response to “Muscle and the mind: The combination of creatine and exercise for depression?”1 year ago
- Longitudinal brain age in first-episode mania youth treated with lithium or quetiapine1 year ago